NFLX Weekly/Daily:
Weekly:
The Weekly chart's ADX numbers are falling such that I'm considering this may break below the PB&J Sweet Spot and potentially dead cross, changing the asset into short mode. It is however within the PB&J buy zone so a bullish reversal candlestick is certainly possible here as well. Bearish MACD divergence and a declining +DI seem to support that this is the end of the bullish wave.
Daily:
As far as Nison's SMA 10/20/200 strategy, shorting this is out of the question until both SMA 10/20 are below SMA 200, and they Dead Cross following. SMA 200 is a 4% drop from here and prior similar price action in this area precipitated an additional -15% drop before reversing bullish after 2 Weeks trading under SMA 200. Given the Weekly and Daily perspective I would close any open positions and only consider reentry on a solid bullish reversal from the SMA 200 zone, and only following a pullback into the SMA 10 / EMA "Sweet Spot" zone after a Golden Cross.
Also, Netflix should pay their damn taxes.
Weekly:
The Weekly chart's ADX numbers are falling such that I'm considering this may break below the PB&J Sweet Spot and potentially dead cross, changing the asset into short mode. It is however within the PB&J buy zone so a bullish reversal candlestick is certainly possible here as well. Bearish MACD divergence and a declining +DI seem to support that this is the end of the bullish wave.
Daily:
As far as Nison's SMA 10/20/200 strategy, shorting this is out of the question until both SMA 10/20 are below SMA 200, and they Dead Cross following. SMA 200 is a 4% drop from here and prior similar price action in this area precipitated an additional -15% drop before reversing bullish after 2 Weeks trading under SMA 200. Given the Weekly and Daily perspective I would close any open positions and only consider reentry on a solid bullish reversal from the SMA 200 zone, and only following a pullback into the SMA 10 / EMA "Sweet Spot" zone after a Golden Cross.
Also, Netflix should pay their damn taxes.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.